↓ Skip to main content

Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering?

Overview of attention for article published in Frontiers in Pharmacology, August 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
38 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering?
Published in
Frontiers in Pharmacology, August 2022
DOI 10.3389/fphar.2022.972046
Pubmed ID
Authors

Andrea Zanello, Massimo Bortolotti, Stefania Maiello, Andrea Bolognesi, Letizia Polito

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 16%
Other 3 8%
Unspecified 3 8%
Student > Master 3 8%
Student > Postgraduate 2 5%
Other 5 13%
Unknown 16 42%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 18%
Unspecified 3 8%
Medicine and Dentistry 3 8%
Chemistry 2 5%
Agricultural and Biological Sciences 2 5%
Other 3 8%
Unknown 18 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 September 2022.
All research outputs
#15,030,292
of 23,884,161 outputs
Outputs from Frontiers in Pharmacology
#5,126
of 17,739 outputs
Outputs of similar age
#190,109
of 388,396 outputs
Outputs of similar age from Frontiers in Pharmacology
#258
of 1,384 outputs
Altmetric has tracked 23,884,161 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,739 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 388,396 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,384 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.